Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Telomeric dna" patented technology

Bisfatty amido substituted quinazolone derivatives as well as preparation method and use thereof as anti-cancer drugs

The invention discloses a dual fatty ammonia substituted quinazolinone derivative, represented as formula (I), wherein n is 1, 2, 3, 4 or 5, R1 and R2 are same or different, selected from the alkyl of H and C1-6, and naphthenic group, piperidyl, morpholinyl, piperazinyl or quinoxaline of C3-6. The derivative has strong interaction on the telomere DNA rich with guanine and c-myc DNA of proto-oncogene, strong inhibition on telomere / telomerase of cancer cell and strong inhibition on the c-myc expression of proto-oncogene. The derivative has low toxicity and side effect, which can be developed to a new anti-tumor drug. The derivative has simple preparation method, cheap materials and strong inhibition on various cancer cell lines, which can be prepared into anti-tumor drug, with wide application.
Owner:SUN YAT SEN UNIV

Quinazoline derivative and preparation method thereof and application of quinazoline derivative for preparing anticancer drugs

The invention belongs to the fields of drugs and chemical industry, and discloses a quinazoline derivative and a preparation method thereof and an application of the quinazoline derivative used as an anticancer drug. The structural formula of the quinazoline derivative is shown in the specifications, wherein R1 is NH(CH2)mNR5 or NH(CH2)m-Ar; R2 is NHCO(CH2)n NR5, NHCO(CH2)n-Ar, NHCO(CH2)nNH(CH2)nNR5 or NHCO(CH2)nNH(CH2)n-Ar; R3 is F, Cl, Br, I, H, CH3, SO2CH3 or OCH3; R4 is H, NHCO(CH2)nNR5, NHCO(CH2)n-Ar, NHCO(CH2)nNH(CH2)nNR5 or NHCO(CH2)nNH(CH2)n-Ar; -Ar represents various aromatic rings comprising various aromatic heterocyclic rings; m is equal to 2, 3 or 4; n is equal to 1, 2, 3, 4 or 5; and R5 represents alkyl of C1-6, cycloalkyl of C3-6, piperidyl, morpholinyl, piperazinyl or quinoxalinyl. The invention simultaneously discloses the preparation method of the quinazoline derivative and the application of the quinazoline derivative used as the anticancer drug. The experiment proves that the quinazoline derivative of the invention has strong inhibiting effect on telomere DNA expression, has obvious inhibiting effect on various kinds of cancer cell strains, has low toxicity to normal cells, and has wide application prospects in preparation of anticancer drugs.
Owner:SUN YAT SEN UNIV

Peptide derivative of benzfuran quinoline and preparation method thereof and application thereof as antitumor medicament

The invention belongs to the fields of medicaments and chemical industry, and discloses a peptide derivative of benzfuran quinoline and a preparation method thereof and an application thereof as an antitumor medicament. The structural formula of the peptide derivative of benzfuran quinoline is shown in the specifications, wherein R is a peptide chain, i.e., R, GG, GR, GK, GH, GF, HR, KR, FR, GGR, GFR, GFRK, GFHR or GGGR; R represents arginine; G represents glycine; K represents lysine; H represents histidine; and F represents phenyl alanine. The invention further discloses a preparation method of the peptide derivative of benzfuran quinoline and an application of the peptide derivative as an anticancer medicament. As proved by an experiment, the peptide derivative of benzfuran quinoline related to the invention has a very strong inhibiting effect on the expression of telomere DNAs (Deoxyribose Nucleic Acids) and proto-oncogene DNAs such as c-myc and the like, a remarkable inhibiting effect on various cancer cell lines, low toxicity on normal cells and a wide application space on the preparation of an anticancer medicament.
Owner:SUN YAT SEN UNIV

Telomere length detection method and kit

The invention provides a human chromosome telomere length rapid quantitative detection method and a kit thereof. The method is characterized in that the chromosomal telomere DNA length and changing rate are accurately measured. The basic principle is that the temperature of the chromosome telomere DNA is quickly changed from 98 DEG C to 50 DEG C, to achieve rapid cooling of the temperature and to achieve the purpose of hybridization of a liquid phase double-stranded probe and nucleic acid molecules. By detecting the fluorescence value before and after the hybridization, the fluorescence change value is calculated and converted to the fluorescence change amount corresponding to the unit DNA to be detected, that is, the change amount of the fluorescence value detected before and after the hybridization respectively is divided by the amount of the DNA for the hybridization, to indicate the relative length of the telomere DNA. According to the method, the hybridization temperature and temperature dropping time are strictly controlled; the renaturation of the telomere DNA is minimized, so that the telomere DNA is more fully hybridized with the probe. Therefore, the method has the advantages of being accurate, fast, cheap, convenient, efficient, time-saving and effort-saving, and providing a simple and practical technical method for the telomere DNA length detection.
Owner:张晓

Application of polypyridyl ruthenium complex [Ru(bpy)2(dppzi)]<2+>, and application method thereof

The invention relates to an application of a polypyridyl ruthenium complex [Ru(bpy)2(dppzi)]<2+>, wherein the polypyridyl ruthenium complex [Ru(bpy)2(dppzi)]<2+> can be adopted as a molecular recognition reagent for recognizing a G-quadruplex structure and an i-motif structure of telomere DNA. According to the present invention, the polypyridyl ruthenium complex [Ru(bpy)2(dppzi)]<2+> provides different bonding capacities for the G-quadruplex structure and the i-motif structure of the telomere DNA, and the polypyridyl ruthenium complex [Ru(bpy)2(dppzi)]<2+> provides better bonding capacity for the G-quadruplex structure of the telomere DNA compared to the i-motif structure of the telomere DNA, such that the polypyridyl ruthenium complex [Ru(bpy)2(dppzi)]<2+> can be adopted as the good molecular recognition reagent, wherein the polypyridyl ruthenium complex [Ru(bpy)2(dppzi)]<2+> is respectively added to the DNA solution containing the G-quadruplex structure and the DNA solution containing the i-motif structure, a fluorescence titration method or an ultraviolet titration method is adopted, the change of the fluorescence spectrum or the ultraviolet absorption spectrum is observed, and the two important structures of the telomere DNA can be effectively recognized and distinguished.
Owner:TONGJI UNIV

Telomerase inhibitor screening system based on SPR technology

InactiveCN106442421AEfficient screeningAccelerate Screening Development EffortsMaterial analysis by optical meansMetal coatingTelomerase
The invention provides a telomerase inhibitor screening system based on an SPR technology. The system comprises a kit and an SPR chip, wherein the kit is provided with a first reaction liquid, a second reaction liquid and a diluent, the first reaction liquid comprises 100-120 mmol / L dNTP and a dNTP stock solution, and the second reaction liquid comprises telomerase and a telomerase stock solution; the diluent is 10-200 mmol / L PB or a PBS buffer solution which has pH of 7.3; the SPR chip is provided with a glass plate, a metal coating film covering the glass plate and telomeric DNA connected with the coating film. The telomerase inhibitor screening system based on the SPR technology can achieve simple, fast, stable and reliable screening work of telomerase inhibitors through mature SPR equipment on the market.
Owner:SUZHOU INST OF BIOMEDICAL ENG & TECH CHINESE ACADEMY OF SCI

Quinazoline derivative and preparation method thereof and application of quinazoline derivative for preparing anticancer drugs

The invention belongs to the fields of drugs and chemical industry, and discloses a quinazoline derivative and a preparation method thereof and an application of the quinazoline derivative used as an anticancer drug. The structural formula of the quinazoline derivative is shown in the specifications, wherein R1 is NH(CH2)mNR5 or NH(CH2)m-Ar; R2 is NHCO(CH2)n NR5, NHCO(CH2)n-Ar, NHCO(CH2)nNH(CH2)nNR5 or NHCO(CH2)nNH(CH2)n-Ar; R3 is F, Cl, Br, I, H, CH3, SO2CH3 or OCH3; R4 is H, NHCO(CH2)nNR5, NHCO(CH2)n-Ar, NHCO(CH2)nNH(CH2)nNR5 or NHCO(CH2)nNH(CH2)n-Ar; -Ar represents various aromatic rings comprising various aromatic heterocyclic rings; m is equal to 2, 3 or 4; n is equal to 1, 2, 3, 4 or 5; and R5 represents alkyl of C1-6, cycloalkyl of C3-6, piperidyl, morpholinyl, piperazinyl or quinoxalinyl. The invention simultaneously discloses the preparation method of the quinazoline derivative and the application of the quinazoline derivative used as the anticancer drug. The experiment proves that the quinazoline derivative of the invention has strong inhibiting effect on telomere DNA expression, has obvious inhibiting effect on various kinds of cancer cell strains, has low toxicity to normal cells, and has wide application prospects in preparation of anticancer drugs.
Owner:SUN YAT SEN UNIV

Traditional Chinese medicine compound preparation for treating liver cancer and production method thereof

ActiveCN103948736BGood anti-cancer and anti-cancer effectReduce expansionDigestive systemAntineoplastic agentsTelomeraseCancer cell
The invention discloses a Chinese herbal medicine compound preparation for treating liver cancer and a production method thereof. The Chinese herbal medicine compound preparation is mainly prepared from the following main Chinese herbal medicine raw materials in parts by weight: 1-15 parts of herba acalypha australis, 5-30 parts of herba sarcandrae, 5-15 parts of tape grass and 5-15 parts of radix scrophulariae. The production method of the Chinese herbal medicine compound preparation is characterized in that the medicines are prepared into an oral solution, a capsule, a tablet, a granule and the like through modern pharmaceutical production techniques such as water extraction, alcohol precipitation, concentration and powder preparation. The traditional Chinese medicine preparation has the effects of dispelling wind, removing meridian obstruction, promoting blood circulation to remove blood stasis and the like, also plays an anticancer effect, and can be used for slowing down and gradually shortening DNA (Deoxyribonucleic Acid) replication of telomeres of cancer cells by inhibiting the telomerase activity of the cancer cells so that the growth of the cancer cells is slowed down and finally the cancer cells head towards apoptosis, so the Chinese herbal medicine compound preparation is suitable for treating the liver cancer, the stomach cancer and the like.
Owner:广西云球生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products